Publications

Logo for NCBI, a double helix with the letters NCBI below

For a current list of my publications archived in PubMed, please visit the link above

logo for ORCID, a Green Circle with ID inside

To view my ORCiD account, please visit the link above

Selected Publications

Song J, Forrest N, Gordon A, Kottyan L, Mittendorf KF, Wei WQ, Ramsey-Goldman R, Walunas T, Kho A. Utilization of electronic health record data to evaluate the association of urban environment on systemic lupus erythematosus symptoms. Rheumatology (Oxford). 2022 Nov 16:keac647. doi: 10.1093/rheumatology/keac647. Epub ahead of print. PMID: 36383166.

Van Egeren D, Kohli K, Warner JL, Bedard PL, Riely G, Lepisto E, Schrag D, LeNoue-Newton M, Catalano P, Kehl KL, Michor F; AACR Project GENIE Consortium represented by Shawn Sweeney. Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis. Sci Rep. 2022 Nov 9;12(1):19055. doi: 10.1038/s41598-022-21448-1. PMID: 36351964; PMCID: PMC9646734. [Consortium Contributor Only]

Lindberg NM, Mittendorf KF, Duenas DM, Anderson K, Koomas A, Kraft SA, Okuyama S, Shipman KJ, Vandermeer ML, Goddard KA, Wilfond BS, McMullen C. Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts. Perm J. 2022 Jun 29;26(2):28-39. doi: 10.7812/TPP/21.091. Epub 2022 Jun 17. PMID: 35933674.

Ferket BS, Baldwin Z, Murali P, Pai A, Mittendorf KF, Russell HV, Chen F, Lynch FL, Lich KH, Hindorff LA, Savich R, Slavotinek A, Smith HS, Gelb BD, Veenstra DL. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Genet Med. 2022 Jul 13:S1098-3600(22)00813-9. doi: 10.1016/j.gim.2022.06.004. Epub ahead of print. PMID: 35833928.

Muenzen KD, Amendola LM, Kauffman TL, Mittendorf KF, Bensen JT, Chen F, Green R, Powell BC, Kvale M, Angelo F, Farnan L, Fullerton SM, Robinson JO, Li T, Murali P, Lawlor JMJ, Ou J, Hindorff LA, Jarvik GP, Crosslin DR. Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience. HGG Adv. 2022 May 20;3(3):100120. doi: 10.1016/j.xhgg.2022.100120. PMID: 35707062; PMCID: PMC9190054.

Mittendorf KF, Lewis HS, Duenas DM, Eubanks DJ, Gilmore MJ, Goddard KAB, Joseph G, Kauffman TL, Kraft SA, Lindberg NM, Reyes AA, Shuster E, Syngal S, Ukaegbu C, Zepp JM, Wilfond BS, Porter KM. Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews. Hered Cancer Clin Pract. 2022 Jun 10;20(1):22. doi: 10.1186/s13053-022-00231-3. PMID: 35689290; PMCID: PMC9188215.

Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B. Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. Cancer. 2022 Jun 9. doi: 10.1002/cncr.34349. [Epub ahead of print]. PMID: 35679147.

Amendola LM, Shuster E, Leo MC, Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP. Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. Genetics in Medicine. 2022 Mar 16;. doi: 10.1016/j.gim.2022.02.006. [Epub ahead of print] PubMed PMID: 35305866.

O'Daniel JM, Ackerman S, Desrosiers LR, Rego S, Knight SJ, Mollison L, Byfield G, Anderson KP, Danila MI, Horowitz CR, Joseph G, Lamoure G, Lindberg NM, McMullen CK, Mittendorf KF, Ramos MA, Robinson M, Sillari C, Madden EB. Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium. Genetics in Medicine. 2022 Feb 25;. doi: 10.1016/j.gim.2022.01.008. [Epub ahead of print] PubMed PMID: 35227608.

Rolf BA, Schneider JL, Amendola LM, Davis JV, Mittendorf KF, Schmidt MA, Jarvik GP, Wilfond BS, Goddard KAB, Ezzell Hunter J. Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment. Journal of Genetic Counseling. 2022 Feb;31(1):230-241. doi: 10.1002/jgc4.1476. Epub 2021 Jul 23. PubMed PMID: 34302314; PubMed Central PMCID: PMC8783924.

Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precision Oncology. 2021;5. doi: 10.1200/PO.21.00233. eCollection 2021. Review. PubMed PMID: 34778694; PubMed Central PMCID: PMC8585306.

Lindberg NM, Gutierrez AM, Mittendorf KF, Ramos MA, Anguiano B, Angelo F, Joseph G. Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned. Personalized Medicine. 2021 Sep;18(5):441-454. doi: 10.2217/pme-2020-0075. Epub 2021 Aug 27. PubMed PMID: 34448595; PubMed Central PMCID: PMC8438935.

Holt ME, Mittendorf KF, LeNoue-Newton M, Jain NM, Anderson I, Lovly CM, Osterman T, Micheel C, Levy M. My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase. JCO Clinical Cancer Informatics. 2021 Sep;5:995-1004. doi: 10.1200/CCI.21.00084. PubMed PMID: 34554823; PubMed Central PMCID: PMC8807017.

Mittendorf KF*, Kauffman TL*, Amendola LM, Anderson KP, Biesecker BB, Dorschner MO, Duenas DM, Eubanks DJ, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Lee SSJ, Leo MC, Liles EG, Lindberg NM, Muessig KR, Okuyama S, Porter KM, Riddle LS, Rolf BA, Rope AF, Zepp JM, Jarvik GP, Wilfond BS, Goddard KAB. Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. Contemporary Clinical Trials. 2021 Jul;106:106432. doi: 10.1016/j.cct.2021.106432. Epub 2021 May 11. PubMed PMID: 33984519; PubMed Central PMCID: PMC8336568. Corrigendum in doi: 10.1016/j.cct.2022.106682

Mittendorf KF*, Ukaegbu C*, Gilmore MJ, Lindberg NM, Kauffman TL, Eubanks DJ, Shuster E, Allen J, McMullen C, Feigelson HS, Anderson KP, Leo MC, Hunter JE, Sasaki SO, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Adaptation and early implementation of the PREdiction model for gene mutations (PREMM 5™) for lynch syndrome risk assessment in a diverse population. Familial Cancer. 2021 Mar 23. Online ahead of print. doi: 10.1007/s10689-021-00243-3. PubMed PMID: 33754278; PubMed Central PMCID: PMC8458476.

Kraft SA, Porter KM, Duenas DM, Guerra C, Joseph G, Lee SS, Shipman KJ, Allen J, Eubanks D, Kauffman TL, Lindberg NM, Anderson K, Zepp JM, Gilmore MJ, Mittendorf KF, Shuster E, Muessig KR, Arnold B, Goddard KAB, Wilfond BS. Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study. AJOB Empirical Bioethics. 2021. 12, 1-11. PubMed PMID: 32981477; PubMed Central PMCID: PMC7785634.

Hutchison JM, Shi KC, Scheidt HA, Fantin SM, Parson KF, Pantelopulos GA, Harrington HR, Mittendorf KF, Qian S, Stein RA, Collier SE, Chambers MG, Katsaras J, Voehler MW, Ruotolo BT, Huster D, McFeeters RL, Straub JE, Nieh MP, Sanders CR. Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane Proteins. Journal of the American Chemical Society. 2020. 142, 12715-12729. PubMed PMID: 32575981; PubMed Central PMCID: PMC7924963.

Jain N, Mittendorf KF, Holt M, Lenoue-Newton M, Maurer I, Miller C. Stachowiak M, Botyrius M, Cole J, Micheel C, The My Cancer Genome clinical trial data model and trial curation workflow. Journal of the American Medical Informatics Association. 2020. 27, 1057-1066. PubMed PMID: 32483629; PubMed Central PMCID: PMC7647323.

Mittendorf KF, Hunter JE, Schneider JL, Shuster E, Rope AF, Zepp J, Gilmore MJ, Muessig KR, Davis JV, Kauffman TL, Bergen KM, Wiesner GL, Acheson LS, Peterson SK, Syngal S, Reiss JA, Goddard KAB. Recommended Care and Care Adherence Following a Diagnosis of Lynch Syndrome: A mixed-methods study. Hereditary Cancer in Clinical Practice. 2019. 17 (31). PubMed PMID: 31890059; PubMed Central PMCID: PMC6915941.

Paquin RS, Mittendorf KF, Lewis MA, Hunter JE, Lee K, Berg JS, Williams MS, Goddard KAB. Expert and Lay Perspectives on Burden, Risk, Tolerability, and Acceptability of Clinical Interventions for Genetic Disorders. Genetics in Medicine. 2019 Nov. 21(11):2561-2568. PubMed PMID: 31028355; PubMed Central PMCID: PMC6815237.

Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld, Lee K, Lindor NM, Martin CL, Milosavljevic, Mittendorf KF, Muessig KR, O’Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Lygia N, Sobriera M, Weaver MA, Williams MS, Evans JP, Goddard KAB on behalf of the ClinGen Resource. Evidence‐based Assessments of Clinical Actionability in the Context of Secondary Findings: Updates from ClinGen's Actionability Working Group. Human Mutation. 2018. 39, 1677-1685. PubMed PMID: 30311382; PubMed Central PMCID: PMC6211797.

Naleway A, Mittendorf KF, Irving S, Henninger M, Crane B, Smith N, Daley M, Gee J. Primary Ovarian Insufficiency and Adolescent Vaccination. Pediatrics. 2018. 142, e20180943. PubMed PMID: 30131438; PubMed Central PMCID: PMC6719304.

Levy MA, Micheel C, Jain N, Mittendorf K. Assessment of Actionability of Cancer Genomic Testing Panels Based on a Structured Clinical Trial Knowledge Base. Journal of Clinical Oncology. May 20, 2017. 35, no. 15_suppl 6533-6533. [abstract]

Levy MA, Osterman T, Jain N, Mittendorf K, Micheel C. Utility of Adding Clinical Data to a Molecular Results Portal for improving clinical trial prescreening efficiency. Journal of Clinical Oncology. May 30, 2017. 35, no. 15_suppl. [abstract]

Mittendorf KF*, Marinko JT*, Hampton CM, Ke Z, Hadziselimovic A, Schlebach JP, Law CL, Li J, Wright ER, Sanders CR, Ohi MD. Peripheral Myelin Protein 22 Alters Membrane Architecture. Science Advances. 2017. 3, e1700220. PubMed PMID: 28695207; PubMed Central PMCID: PMC5498104.

Takizawa Y, Binshtein E, Erwin AL, Pyburn TM, Mittendorf KF, and Ohi MD. While the Revolution Will Not Be Crystalized, Biochemistry Reigns Supreme. Protein Science, 2017. 26, 69-81. PubMed PMID: 27673321; PubMed Central PMCID: PMC5192976.

Schlebach JP, Narayan M, Alford C, Mittendorf KF, Carter BD, Li J, Sanders CR. Conformational Stability and Pathogenic Misfolding of the Integral Membrane Protein PMP22. Journal of the American Chemical Society, 2015. 137, 8758-8768. PubMed PMID: 26102530; PubMed Central PMCID: PMC4507940.

Mittendorf KF*, Kroncke BM*, Meiler J, Sanders CS. Homology Model of PMP22 Suggests Most Mutations Resulting in Severe Peripheral Neuropathy Disrupt Packing of Transmembrane Helices. Biochemistry, 2014. 48, 1-34. PubMed PMID: 25243937; PubMed Central PMCID: PMC4188248. Highlighted on Biochemistry Homepage.

Song Y*, Mittendorf KF*, Lu Z, Sanders CR. Impact of Bilayer Lipid composition on the Structure and Topology of the Transmembrane Amyloid Precursor C99 Protein. Journal of the American Chemical Society, 2014. 136, 4093-4096. PubMed PMID: 24564538; PubMed Central PMCID: PMC3985881.

Schlebach JP, Peng D, Kroncke BM, Mittendorf KF, Marayan M, Carter BD, Sanders CR. Reversible Folding of Human Peripheral Myelin Protein 22, a Tetraspan Membrane Protein. Biochemistry 2013. 52, 3229-3241. PubMed PMID: 23639031; PubMed Central PMCID: PMC3762913.

Mittendorf KF, Deatherage CL, Ohi MD, Sanders CR. Tailoring of Membrane Proteins by Alternative Splicing of Pre-mRNA. Biochemistry, 2012. 51, 5541-5556. PubMed PMID: 22708632; PubMed Central PMCID: PMC3448030.

Sanders CR and Mittendorf KF. Tolerance to Changes in Membrane Lipid Composition as a Selected Trait of Membrane Proteins. Biochemistry, 2011. 50, 7858-7867. PubMed PMID: 21848311; PubMed Central PMCID: PMC3172382. Cover Image.

*Authors contributed equally

Get in Touch